Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases-Retrospective Analysis of 219 Patients.

Jonas LinYannik KaiserBenedikt Wiestler Denise BernhardtStephanie E CombsClaire DelbridgePhilipp J JostJens GemptAmir Kaywan Aftahy

Published in: Cancers (2023)

RTB is a strong prognostic factor for survival in patients with recurrent BMs. Operated patients with recurrent BMs showed longer survival independent of systemic progression. Maximal cytoreduction should be targeted to achieve better long-term outcomes.

Keyphrases

prognostic factors
brain metastases
small cell lung cancer
free survival
cross sectional
heart rate
risk factors
blood pressure
cancer therapy
body composition
resistance training